Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Bai Jing Ding"'
1
Akademický článek
Folic acid‐modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation
Autor: Tong‐Yuan Lin, Jia‐Li Chang, Yan Xun, Yi Zhao, Wang Peng, Wang Yang, Bai‐Jing Ding, Wei‐Dong Chen
Publikováno v: Kaohsiung Journal of Medical Sciences, Vol 36, Iss 5, Pp 344-353 (2020)
Abstract The aim of present study was to develop folic acid (FA)‐modified nonionic surfactant vesicles (NISVs, niosomes) as carrier systems for targeted delivery of gambogenic acid (GNA). The FA‐GNA‐NISVs exhibited a mean particle size of 180.7
Externí odkaz: https://doaj.org/article/1228b160e120485f9d8613797db3a948
Zobrazit plný text záznamu
2
Akademický článek
A novel drug delivery system of mixed micelles based on poly(ethylene glycol)‐poly(lactide) and poly(ethylene glycol)‐poly(ɛ‐caprolactone) for gambogenic acid
Autor: Tong‐Yuan Lin, Ting‐Ting Zhu, Yan Xun, Yun‐Song Tao, Yu‐Qin Yang, Jia‐Li Xie, Xiao‐Ming Zhang, Shi‐Xiong Chen, Bai‐Jing Ding, Wei‐Dong Chen
Publikováno v: Kaohsiung Journal of Medical Sciences, Vol 35, Iss 12, Pp 757-764 (2019)
Abstract In this study, a novel mixed polymeric micelles formed from biocompatible polymers, poly(ethylene glycol)‐poly(lactide) (mPEG‐PLA) and poly(ethylene glycol)‐poly(ɛ‐caprolactone) (mPEG‐PCL), used as a novel nanocarrier to encapsula
Externí odkaz: https://doaj.org/article/e583111526e442fbac30b375ce38aee5
Zobrazit plný text záznamu
3
Akademický článek
Differential diagnosis of intestinal tuberculosis from Crohn′s disease and primary intestinal lymphoma in China
Autor: Yun-Yan Liu, Ming-Kai Chen, Zhuo Cao, Shu-Zhong Liu, Bai-Jing Ding
Publikováno v: The Saudi Journal of Gastroenterology, Vol 20, Iss 4, Pp 241-247 (2014)
Background/Aims: There are many similarities and overlaps in clinical, radiological, endoscopic, and histological features among intestinal tuberculosis (ITB), Crohn′s disease (CD), and primary intestinal lymphoma (PIL), and the differential diagno
Externí odkaz: https://doaj.org/article/1794aef9d4c0452e8f3203a6991d1598
Zobrazit plný text záznamu
4
Folic acid‐modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation
Autor: Bai-Jing Ding, Wang Yang, Jia‐Li Chang, Lin Tongyuan, Weidong Chen, Wang Peng, Yi Zhao, Yan Xun
Publikováno v: Kaohsiung Journal of Medical Sciences, Vol 36, Iss 5, Pp 344-353 (2020)
The aim of present study was to develop folic acid (FA)‐modified nonionic surfactant vesicles (NISVs, niosomes) as carrier systems for targeted delivery of gambogenic acid (GNA). The FA‐GNA‐NISVs exhibited a mean particle size of 180.77 ± 2.41
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1c8154a16b479f700f28167e1421fc4
https://doaj.org/article/1228b160e120485f9d8613797db3a948
Zobrazit plný text záznamu
5
A novel drug delivery system of mixed micelles based on poly(ethylene glycol)‐poly(lactide) and poly(ethylene glycol)‐poly(ɛ‐caprolactone) for gambogenic acid
Autor: Lin Tongyuan, Yan Xun, Bai-Jing Ding, Yu-Qin Yang, Yun-Song Tao, Xiao-Ming Zhang, Jia-Li Xie, Zhu Tingting, Weidong Chen, Shi-Xiong Chen
Publikováno v: Kaohsiung Journal of Medical Sciences, Vol 35, Iss 12, Pp 757-764 (2019)
In this study, a novel mixed polymeric micelles formed from biocompatible polymers, poly(ethylene glycol)‐poly(lactide) (mPEG‐PLA) and poly(ethylene glycol)‐poly(ɛ‐caprolactone) (mPEG‐PCL), used as a novel nanocarrier to encapsulate gambog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2caa7a57d1225b7fad014caf7b646d9
https://doi.org/10.1002/kjm2.12110
Zobrazit plný text záznamu
6
Anti-TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta-analysis
Autor: Chun Jin Xu, Wei Wu, Zhan Ju Liu, Bai Jing Ding, Liang Chen
Publikováno v: Journal of digestive diseasesREFERENCES. 22(7)
Objective The current concern exists regarding the efficacy and safety of biological agent monotherapy versus combination therapy with an immunomodulator (IM) in patients with inflammatory bowel disease (IBD). We performed a meta-analysis of results
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01391b5c058fe5df72ce9d02d795cf84
https://pubmed.ncbi.nlm.nih.gov/34048629
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje